RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 125 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $33,781 | -11.4% | 33,119 | +13.8% | 0.00% | – |
Q2 2023 | $38,116 | -0.8% | 29,096 | 0.0% | 0.00% | – |
Q1 2023 | $38,407 | -24.4% | 29,096 | -14.0% | 0.00% | – |
Q4 2022 | $50,774 | +41.0% | 33,849 | +11.6% | 0.00% | – |
Q3 2022 | $36,000 | -7.7% | 30,338 | -13.2% | 0.00% | – |
Q2 2022 | $39,000 | -35.0% | 34,933 | +74.9% | 0.00% | – |
Q1 2022 | $60,000 | +13.2% | 19,969 | 0.0% | 0.00% | – |
Q4 2021 | $53,000 | -29.3% | 19,969 | -3.5% | 0.00% | – |
Q3 2021 | $75,000 | +4.2% | 20,700 | +25.2% | 0.00% | – |
Q2 2021 | $72,000 | +94.6% | 16,531 | +54.5% | 0.00% | – |
Q1 2021 | $37,000 | -11.9% | 10,700 | -11.6% | 0.00% | – |
Q4 2020 | $42,000 | +44.8% | 12,100 | 0.0% | 0.00% | – |
Q3 2020 | $29,000 | +11.5% | 12,100 | -14.2% | 0.00% | – |
Q2 2020 | $26,000 | -90.5% | 14,100 | -81.7% | 0.00% | -100.0% |
Q1 2018 | $273,000 | +9.6% | 77,181 | +20.5% | 0.00% | 0.0% |
Q4 2017 | $249,000 | +118.4% | 64,062 | +42.5% | 0.00% | 0.0% |
Q3 2017 | $114,000 | +8.6% | 44,971 | +16.8% | 0.00% | 0.0% |
Q2 2017 | $105,000 | +87.5% | 38,508 | +126.5% | 0.00% | – |
Q1 2017 | $56,000 | – | 17,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |